EPIC: phase III trial of cetuximab plus irinotecan after fluoropyrimidine and oxaliplatin failure in patients with metastatic colorectal cancer.

Details

Language :

English

ISSN :

0732183X

Volume :

26

Issue :

14

Database :

Supplemental Index

Journal :

Journal of Clinical Oncology

Publication Type :

Academic Journal

Accession number :

105736729

Full Text :

https://doi.org/10.1200/JCO.2007.13.1193